Osimertinib or platinum-pemetrexed in EGFR T790M-Positive lung cancer
- T. S. Mok
- , Y. L. Wu
- , M. J. Ahn
- , M. C. Garassino
- , H. R. Kim
- , S. S. Ramalingam
- , F. A. Shepherd
- , Y. He
- , H. Akamatsu
- , W. S.M.E. Theelen
- , C. K. Lee
- , M. Sebastian
- , A. Templeton
- , H. Mann
- , M. Marotti
- , S. Ghiorghiu
- , V. A. Papadimitrakopoulou
- Prince of Wales Hospital Hong Kong
- Guangdong Academy of Medical Sciences
- Sungkyunkwan University
- IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
- Yonsei University
- Emory University
- Princess Margaret Cancer Centre
- Daping Hospital, the Third Military Medical University
- Wakayama Medical University
- Netherlands Cancer Institute
- St. George Hospital
- Goethe University Frankfurt
- AstraZeneca
- University of Texas MD Anderson Cancer Center
Research output: Contribution to journal › Article › peer-review
3198
Link opens in a new tab
Scopus
citations